This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Nicholas Minutolo
Introduction
Nicholas Minutolo is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of cellular therapy, particularly through his innovative work at the University of Pennsylvania. His expertise and dedication have led to the development of groundbreaking technologies that have the potential to transform medical treatments.
Latest Patents
Nicholas Minutolo holds a patent for a DOTA binding chimeric antigen receptor for cellular therapy. This invention represents a significant advancement in the field, showcasing his ability to merge scientific research with practical applications. The patent highlights his commitment to improving therapeutic options for patients.
Career Highlights
Throughout his career, Minutolo has been involved in various research projects that focus on enhancing cellular therapies. His work at the University of Pennsylvania has positioned him as a key figure in the development of innovative treatment methods. His contributions have not only advanced scientific knowledge but also provided new hope for patients in need of effective therapies.
Collaborations
Minutolo has collaborated with notable colleagues, including Daniel J. Powell and Michael Farwell. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
In summary, Nicholas Minutolo is a prominent inventor whose work in cellular therapy is paving the way for future innovations in medical treatments. His dedication to research and collaboration exemplifies the spirit of innovation that drives progress in the field.